Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 65862-906

The text describes a chart or graph showing the mean change in FEV1 (forced expiratory volume) measured on day 14 after dosing with a combination of ipratropium bromide, albuterol, and albuterol sulfate inhalation solution. The chart displays the hour intervals after dosing along the x-axis from 1 to 8 and the change in FEV1 on the y-axis from 0.05 to an undetermined value, measured in some unit.*

This is a description of a medicine called Ipratropium Bromide and Albuterol Sulfate Inhalation Solution, USP. It comes in a pouch containing a 3ml sterile vial, and each vial contains 0.5mg of ipratropium bromide and 3mg of albuterol sulfate. It can only be used for inhalation and should be stored between 2 to 25°C. The medicine's usual dosage is not given and requires accompanying prescribing information. The manufacturer is Aurobindo Pharma USA, Inc.*

This is a description of a medication for inhalation called Ipratropium Bromide and Albuterol Sulfate. The medication is distributed by Aurobindo Pharma USA, Inc. Each 3mL vial contains 0.5 mg of ipratropium bromide USP and 3 mg of albuterol sulfate USP, which is equivalent to 2.5 mg of albuterol base. The medication should be protected from light and the unit dose vials should remain stored in the protective foil pouch. Once removed from the pouch, the individual vials should be used within one week. The medication should be discarded if the solution is not colorless. The usual dosage should be determined based on the accompanying prescribing information. This medication is only for inhalation purposes and should be stored between 2° to 25°C. It is important to keep this medication out of reach of children.*

This is a prescription drug called "Ipratropium Bromide and Albuterol Sulfate Inhalation Solution, USP." It comes in a sterlie unit-dose vial and is for inhalation only. Each vial contains 0.5 mg ipratropium bromide USP and 3 mg albuterol sulfate USP. The carton contains 30 pouches of 3 ml vial each. The drug is distributed by Aurobindo Pharma USA, Inc.*

This is a description of a medication called Ipratropium Bromide and Albuterol Sulfate Inhalation Solution. It is a sterile solution consisting of 0.5mg ipratropium bromide USP and 3mg albuterol sulfate USP in each 3mL unit-dose vial. The solution is for inhalation only and is distributed in a carton that contains six pouches of five 3mL vials. The medication is directed and prescribed by a physician with the recommended dosage provided in the prescribing information. It is important for the pharmacist to detach the "Patient's Instruction for Use" and dispense it with the solution. The medication should be stored between 21-25° Celsius, protected from light, and should only be used within one week of being removed from the protective pouch.*

The given text describes an inhalation solution containing 0.5 mg of ipratropium bromide USP and 3 mg of albuterol sulfate USP in each unit-dose vial. The carton comprises 12 pouches, each containing five 3 mL sterile vials. The drug is intended for inhalation purposes only, and each vial consists of sodium chloride, edetate disodium, hydrochloric acid, and sterile water for injection in addition to active ingredients. It is recommended to be stored in the protective foil pouch always and discard if not colorless. The usual dosage instructions are provided, and it is mandatory to use as directed by a doctor and not to exceed the dosage limit. The packaging includes patient instructions to use the solution. Aurobindo Pharma USA, Inc., has distributed the product, which is produced in India.*

The text seems to show chemical notation for a compound called "albuterol sulfate" and an image of its chemical structure, as shown in Figure 1.*

This is a diagram illustrating the chemical structure of ipratropium bromide.*